Mouse-on-mouse (MOM) staining protocol

The Mouse-on-Mouse (MOM) staining protocol is designed to address the challenges of using mouse monoclonal antibodies on mouse tissue. This technique is essential for researchers conducting  immunohistochemistry(IHC), as the protocol is specifically designed to improve the detection of specific antigens in tissue samples where high background staining often compromises results. The protocol outlines effective strategies to minimize non-specific binding caused by endogenous mouse IgG and Fc receptors. By incorporating specialized reagents such as F(ab) fragments and polymer-based detection systems, the MOM protocol ensures clearer, more specific staining. This guide is ideal for scientists seeking reliable, reproducible results in mouse tissue IHC applications, which is crucial for any IHC experiment involving mouse tissues.

Introduction

Staining mouse tissues with mouse monoclonal antibodies presents a unique challenge due to high background interference. The Mouse-on-Mouse (MOM) staining protocol offers a targeted solution to this issue. It provides a step-by-step approach to reduce non-specific binding, particularly from endogenous IgG and Fc receptors. This protocol is especially useful in IHC applications where specificity and clarity are critical. The presence of interfering substances in tissue samples can affect staining outcomes and should be controlled for. By using optimized blocking strategies and validated reagents, and by evaluating antibody performance with a test sample to optimize staining conditions, researchers can achieve high-quality staining results. The MOM protocol is a valuable tool for anyone working with mouse models in biomedical research, pathology, or drug development.

Background and principles

Mouse tissues naturally contain endogenous IgG and Fc receptors, which can bind to mouse monoclonal antibodies and cause high background staining. The MOM protocol addresses this by incorporating specific blocking steps using F(ab) fragments and serum from the host species of the secondary antibody. During these steps, tissue sections are incubated with blocking reagents to prevent unwanted interactions. These components prevent unwanted interactions and enhance signal specificity by reducing nonspecific binding. Additionally, polymer-based detection systems like our Mouse on Mouse Polymer IHC Kit (ab269452) improve sensitivity and reduce background. The protocol emphasizes careful tissue preparation, blocking, and washing to ensure optimal results. Understanding these principles is key to successful IHC staining in mouse-on-mouse applications.

Stage 1 - Methods for reducing background

Materials required

• Mouse on Mouse Polymer IHC Kit (ab269452) is a polymer-based system that provides increased sensitivity and detection simplicity and saves time.
• Alternatively, use Goat anti-Mouse F(ab) fragment (ab6668) for mouse-on-mouse blocking, and combine it with one of our Goat-anti-Mouse secondary antibodies.

Steps

Prepare tissue sections as usual.

At the usual blocking step, block with serum (from same species as the secondary antibody) for 30 min at room temperature.

Wash 3 times for 2 minutes with PBS Tween-20.

Incubate tissue sections with an unconjugated affinity purified F(ab) fragment anti-mouse IgG (H+L) for 1 hour at room temperature, or overnight at 4°C.

Proceed with antibody staining. ​

Fc receptors are present on several cell types, such as macrophages and monocytes, and can bind to the antibody and give additional background staining.

Materials required

• We recommend using F(ab) monomeric secondary antibodies to help reduce background.

Other methods to reduce the general background

To 'clean' the tissue, incubate sections with 1% Triton (in PBS) at room temperature for 30 minutes.

Use TBS-Tween-20 as a washing buffer, as this often gives less background than using PBS-Tween-20.

• Understanding endogenous targets

  In IHC experiments using MOM staining protocols, understanding endogenous targets is essential for achieving accurate results. Mouse tissue samples naturally contain endogenous mouse IgG, which can lead to high background staining when using mouse monoclonal antibodies. This occurs because the secondary antibody, designed to detect the primary antibody, may also bind to endogenous mouse IgG present in the tissue, resulting in non-specific staining and obscuring the detection of target proteins. To address this, it is crucial to block endogenous IgG using unconjugated F(ab) fragments, which occupy potential binding sites and help reduce background staining. Employing isotype controls and performing extensive validation of both primary and secondary antibodies further ensures that staining is specific to the intended target proteins. By carefully blocking endogenous targets and validating reagents, researchers can minimize high background staining and improve the reliability of their immunohistochemistry results in mouse-on-mouse applications.

• Blocking endogenous enzymes

  Blocking endogenous enzymes is a vital step in the MOM staining protocol, especially when working with formalin-fixed paraffin-embedded (FFPE) tissue samples. Enzymes such as alkaline phosphatase, which are naturally present in mouse tissues, can react with detection substrates and cause high background staining if not properly inhibited. To prevent this, researchers often use specific inhibitors like levamisole to block alkaline phosphatase activity, thereby reducing non-specific staining. Additionally, incorporating normal serum or other blocking agents can help minimize background caused by non-specific binding of primary and secondary antibodies. Optimizing the concentration of these blocking agents and adjusting incubation times are important for effective blocking of endogenous enzymes. By carefully blocking endogenous enzymes, researchers can achieve clearer, more specific staining and improve the overall quality of their IHC experiments.

• Comparison to other methods

  Traditional IHC protocols often fail when applied to mouse-on-mouse staining due to cross-reactivity and high background. Unlike standard methods, the MOM protocol includes targeted blocking of endogenous IgG and Fc receptors, which are not typically addressed in conventional workflows. While some researchers attempt to mitigate background using diluted antibodies or extended washing, these approaches are less effective and can compromise signal strength. In contrast, the MOM protocol uses F(ab) fragments and polymer-based detection to enhance specificity and sensitivity. This makes it a superior choice for applications requiring precise localization of antigens in mouse tissues, especially when using mouse primary antibodies in these protocols.

  Optimizing the MOM protocol

  Achieving optimal results with the MOM protocol requires careful attention to several key factors. Using directly conjugated primary antibodies or pre-formed complexes of primary and secondary antibodies can significantly reduce background staining by limiting opportunities for non-specific binding. Blocking endogenous IgG with unconjugated F(ab) fragments is another effective strategy to minimize non-specific staining in mouse tissue samples. It is also important to optimize the concentration of both primary and secondary antibodies, as well as incubation times, to ensure specific binding to target proteins without increasing background. Employing staining tips such as incubating tissue samples with primary antibodies overnight at 4°C can further enhance staining specificity. By systematically optimizing these parameters, researchers can achieve sensitive and specific detection of target proteins in mouse tissues while minimizing unwanted background.

• Advanced techniques in MOM staining

  To further reduce non-specific staining, many protocols now recommend the use of biotin-free reagents and the avoidance of avidin-biotin complexes, which can contribute to background issues. Alternative fixation methods, such as ice-cold acetone, can help decrease autofluorescence and improve the clarity of immunofluorescent staining. Additionally, advanced imaging technologies like confocal microscopy allow for higher resolution and sensitivity in the detection of target proteins. By incorporating these advanced techniques, researchers can achieve more precise and informative results in their MOM staining experiments.

• Limitations

  Despite its advantages, the MOM staining protocol has some limitations. It requires additional reagents such as F(ab) fragments and polymer-based detection kits, which may increase cost and complexity. Optimization is often necessary, as blocking efficiency can vary depending on tissue type and antibody specificity. The protocol may not be suitable for all mouse monoclonal antibodies, particularly those with low affinity or poor tissue penetration. Additionally, over-blocking can reduce signal intensity. Researchers must carefully balance blocking and detection to achieve optimal results. These limitations highlight the importance of pilot testing and protocol customization.

• Troubleshooting

  Common issues in MOM staining include high background, weak signal, and non-specific binding. To reduce background, ensure thorough blocking of endogenous IgG using F(ab) fragments and serum from the secondary antibody host species. If the signal is weak, verify the antibody concentration and incubation times. Use polymer-based detection systems for enhanced sensitivity. Inconsistent staining may result from inadequate washing or tissue preparation; use TBS-Tween instead of PBS-Tween for better results. If Fc receptor binding is suspected, include additional blocking steps. Always validate each step with control tissues to identify and resolve issues efficiently.